Kymera Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC KYMR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

497,026

Value ($000)

38,674

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	38,674	0.0%	497,026	12/31/2025
2025 Q3	11/10/2025	24,894	0.0%	439,825	9/30/2025
2025 Q2	8/12/2025	18,735	0.0%	429,304	6/30/2025
2025 Q1	9/15/2025	10,447	0.0%	381,708	3/31/2025
2024 Q4	2/6/2025	15,577	0.0%	387,187	12/31/2024
2024 Q3	11/12/2024	17,363	0.0%	366,841	9/30/2024
2024 Q2	8/12/2024	11,197	0.0%	375,101	6/30/2024
2024 Q1	5/9/2024	14,235	0.0%	354,106	3/31/2024
2023 Q4	2/6/2024	7,808	0.0%	306,692	12/31/2023
2023 Q3	11/8/2023	4,194	0.0%	301,741	9/30/2023
2023 Q2	8/10/2023	6,922	0.0%	301,102	6/30/2023
2023 Q1	5/12/2023	8,844	0.0%	298,497	3/31/2023
2022 Q4	2/13/2023	7,436	0.0%	297,908	12/31/2022
2022 Q3	11/14/2022	6,065	0.0%	278,560	9/30/2022
2022 Q2	8/15/2022	5,052	0.0%	256,542	6/30/2022
2022 Q1	5/13/2022	10,804	0.0%	255,277	3/31/2022
2021 Q4	2/11/2022	15,780	0.0%	248,534	12/31/2021
2021 Q3	11/16/2021	14,288	0.0%	243,225	9/30/2021
2021 Q2	8/16/2021	5,048	0.0%	104,076	6/30/2021
2021 Q1	5/17/2021	2,427	0.0%	62,448	3/31/2021
2020 Q4	2/16/2021	3,803	0.0%	61,334	12/31/2020